Véronique Leblond, MD, PhD, is a Professor in Hematology and Head of the Department of Hematology at Pitié Salpêtrière Hospital in Paris, France. She is also the Chair of the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenström’s Macroglobulinaemia (FCG CLL-WM).
Prof. Leblond is a member of the French Society of Hematology and the American Society of Hematology. She is the author of over 250 research articles, books and chapters.
Speaking on immunotherapies for CLL and Waldenström’s macroglobulinemia
Prof. Leblond’s research is primarily focused on the treatment of chronic lymphocytic leukemia (CLL) and Waldenström’s macroglobulinemia. She is involved in numerous clinical trials investigating novel immunotherapies in these fields.